Table 2 Univariate logistic regression analysis of predictors of hypertension persistence after operation in training group.

From: Predictive model for persistent hypertension after surgical intervention of primary aldosteronism

Variable

OR (95% CI)

P

Age

1.03 (1.0–1.06)

0.013

Male

2.60 (1.53–4.40)

 < 0.001

SBP

1.02 (1.01–1.04)

 < 0.001

DBP

1.02 (1.01–1.04)

0.005

BMI ≥ 25

3.16 (1.84–5.42)

 < 0.001

Duration of HT

1.13 (1.07–1.19)

 < 0.001

Diabetes

6.89 (2.74–17.34)

 < 0.001

HHD

2.42 (1.33–4.43)

0.004

RH

2.13 (1.24–3.66)

0.060

DDD of antihypertensive medication

1.33 (1.12–1.73)

0.002

ARR

0.42 (0.23–0.75)

0.004

PAC

0.13 (0.04–0.40)

 < 0.001

DRC

1.06 (0.94–1.20)

0.347

Lowest serum K+

1.62 (1.05–2.50)

0.030

eGFR

0.98 (0.97–0.99)

 < 0.001

TG

1.14 (0.94–1.39)

0.178

Diameter of nodule

0.66 (0.46–0.94)

0.022

  1. Data are expressed as odds ratio (OR) (95% CI).
  2. SBP systolic blood pressure, DBP diastolic blood pressure, HT hypertension, HHD hypertensive heart disease, RH resistant hypertension, DDD defined daily dose, ARR aldosterone/renin ratio, PAC plasma aldosterone concentration, DRC direct renin concentration, Lowest serum K+ lowest serum potassium in history, eGFR estimated glomerular filtration, TG triglyceride.